Logo image of MATV

MATIV HOLDINGS INC (MATV) Stock Fundamental Analysis

NYSE:MATV - New York Stock Exchange, Inc. - US8085411069 - Common Stock - Currency: USD

7.24  -0.34 (-4.49%)

After market: 7.23 -0.01 (-0.14%)

Fundamental Rating

4

Taking everything into account, MATV scores 4 out of 10 in our fundamental rating. MATV was compared to 85 industry peers in the Chemicals industry. Both the profitability and financial health of MATV have multiple concerns. MATV has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year MATV was profitable.
In the past year MATV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: MATV reported negative net income in multiple years.
Each year in the past 5 years MATV had a positive operating cash flow.
MATV Yearly Net Income VS EBIT VS OCF VS FCFMATV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M -300M

1.2 Ratios

Looking at the Return On Assets, with a value of -21.74%, MATV is doing worse than 83.53% of the companies in the same industry.
Looking at the Return On Equity, with a value of -104.20%, MATV is doing worse than 90.59% of the companies in the same industry.
MATV has a worse Return On Invested Capital (1.41%) than 71.76% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MATV is significantly below the industry average of 6.84%.
Industry RankSector Rank
ROA -21.74%
ROE -104.2%
ROIC 1.41%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
MATV Yearly ROA, ROE, ROICMATV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20 -30

1.3 Margins

With a Operating Margin value of 1.60%, MATV is not doing good in the industry: 75.29% of the companies in the same industry are doing better.
In the last couple of years the Operating Margin of MATV has declined.
MATV has a worse Gross Margin (17.94%) than 71.76% of its industry peers.
MATV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.6%
PM (TTM) N/A
GM 17.94%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
MATV Yearly Profit, Operating, Gross MarginsMATV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20 30

3

2. Health

2.1 Basic Checks

MATV has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, MATV has more shares outstanding
The number of shares outstanding for MATV has been increased compared to 5 years ago.
The debt/assets ratio for MATV is higher compared to a year ago.
MATV Yearly Shares OutstandingMATV Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
MATV Yearly Total Debt VS Total AssetsMATV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

MATV has an Altman-Z score of 1.21. This is a bad value and indicates that MATV is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of MATV (1.21) is worse than 71.76% of its industry peers.
The Debt to FCF ratio of MATV is 33.07, which is on the high side as it means it would take MATV, 33.07 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of MATV (33.07) is comparable to the rest of the industry.
A Debt/Equity ratio of 2.65 is on the high side and indicates that MATV has dependencies on debt financing.
MATV has a worse Debt to Equity ratio (2.65) than 87.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 33.07
Altman-Z 1.21
ROIC/WACC0.16
WACC8.92%
MATV Yearly LT Debt VS Equity VS FCFMATV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

MATV has a Current Ratio of 2.38. This indicates that MATV is financially healthy and has no problem in meeting its short term obligations.
MATV's Current ratio of 2.38 is fine compared to the rest of the industry. MATV outperforms 63.53% of its industry peers.
A Quick Ratio of 1.18 indicates that MATV should not have too much problems paying its short term obligations.
MATV has a Quick ratio (1.18) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.38
Quick Ratio 1.18
MATV Yearly Current Assets VS Current LiabilitesMATV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

4

3. Growth

3.1 Past

The earnings per share for MATV have decreased strongly by -52.58% in the last year.
The earnings per share for MATV have been decreasing by -29.46% on average. This is quite bad
MATV shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -22.19%.
MATV shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.14% yearly.
EPS 1Y (TTM)-52.58%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-800%
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%-3.08%

3.2 Future

The Earnings Per Share is expected to grow by 24.04% on average over the next years. This is a very strong growth
MATV is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 1.28% yearly.
EPS Next Y1.18%
EPS Next 2Y23.36%
EPS Next 3Y24.04%
EPS Next 5YN/A
Revenue Next Year-0.63%
Revenue Next 2Y0.82%
Revenue Next 3Y0.69%
Revenue Next 5Y1.28%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MATV Yearly Revenue VS EstimatesMATV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B
MATV Yearly EPS VS EstimatesMATV Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3

6

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 15.74 indicates a correct valuation of MATV.
Based on the Price/Earnings ratio, MATV is valued a bit cheaper than the industry average as 68.24% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of MATV to the average of the S&P500 Index (27.29), we can say MATV is valued slightly cheaper.
With a Price/Forward Earnings ratio of 7.67, the valuation of MATV can be described as very cheap.
Compared to the rest of the industry, the Price/Forward Earnings ratio of MATV indicates a rather cheap valuation: MATV is cheaper than 90.59% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 21.74, MATV is valued rather cheaply.
Industry RankSector Rank
PE 15.74
Fwd PE 7.67
MATV Price Earnings VS Forward Price EarningsMATV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, MATV is valued a bit cheaper than the industry average as 68.24% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, MATV is valued cheaply inside the industry as 88.24% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 11.46
EV/EBITDA 8.34
MATV Per share dataMATV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MATV does not grow enough to justify the current Price/Earnings ratio.
MATV's earnings are expected to grow with 24.04% in the coming years. This may justify a more expensive valuation.
PEG (NY)13.37
PEG (5Y)N/A
EPS Next 2Y23.36%
EPS Next 3Y24.04%

5

5. Dividend

5.1 Amount

MATV has a Yearly Dividend Yield of 5.28%, which is a nice return.
Compared to an average industry Dividend Yield of 3.57, MATV pays a better dividend. On top of this MATV pays more dividend than 87.06% of the companies listed in the same industry.
MATV's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 5.28%

5.2 History

The dividend of MATV decreases each year by -25.76%.
MATV has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)-25.76%
Div Incr Years0
Div Non Decr Years0
MATV Yearly Dividends per shareMATV Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

5.3 Sustainability

The earnings of MATV are negative and hence is the payout ratio. MATV will probably not be able to sustain this dividend level.
DP-4.86%
EPS Next 2Y23.36%
EPS Next 3Y24.04%
MATV Yearly Income VS Free CF VS DividendMATV Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

MATIV HOLDINGS INC

NYSE:MATV (7/7/2025, 8:04:01 PM)

After market: 7.23 -0.01 (-0.14%)

7.24

-0.34 (-4.49%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-05 2025-08-05/amc
Inst Owners91.21%
Inst Owner ChangeN/A
Ins Owners0.87%
Ins Owner Change29.3%
Market Cap395.52M
Analysts85.71
Price Target13.26 (83.15%)
Short Float %1.96%
Short Ratio1.78
Dividend
Industry RankSector Rank
Dividend Yield 5.28%
Yearly Dividend0.4
Dividend Growth(5Y)-25.76%
DP-4.86%
Div Incr Years0
Div Non Decr Years0
Ex-Date05-23 2025-05-23 (0.1)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)60.16%
Min EPS beat(2)-24.78%
Max EPS beat(2)145.1%
EPS beat(4)2
Avg EPS beat(4)35.03%
Min EPS beat(4)-25.13%
Max EPS beat(4)145.1%
EPS beat(8)5
Avg EPS beat(8)36.59%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-3.01%
Min Revenue beat(2)-7.08%
Max Revenue beat(2)1.06%
Revenue beat(4)1
Avg Revenue beat(4)-3.79%
Min Revenue beat(4)-7.08%
Max Revenue beat(4)1.06%
Revenue beat(8)1
Avg Revenue beat(8)-4.14%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-45.45%
EPS NY rev (1m)-1.6%
EPS NY rev (3m)-15.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.74%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.05%
Valuation
Industry RankSector Rank
PE 15.74
Fwd PE 7.67
P/S 0.2
P/FCF 11.46
P/OCF 4.3
P/B 0.92
P/tB N/A
EV/EBITDA 8.34
EPS(TTM)0.46
EY6.35%
EPS(NY)0.94
Fwd EY13.03%
FCF(TTM)0.63
FCFY8.72%
OCF(TTM)1.68
OCFY23.24%
SpS35.98
BVpS7.84
TBVpS-3.15
PEG (NY)13.37
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -21.74%
ROE -104.2%
ROCE 1.78%
ROIC 1.41%
ROICexc 1.48%
ROICexgc 2.3%
OM 1.6%
PM (TTM) N/A
GM 17.94%
FCFM 1.76%
ROA(3y)-4.64%
ROA(5y)-1%
ROE(3y)-13%
ROE(5y)-2.64%
ROIC(3y)1.6%
ROIC(5y)3.28%
ROICexc(3y)1.67%
ROICexc(5y)3.41%
ROICexgc(3y)3.34%
ROICexgc(5y)7.27%
ROCE(3y)2.03%
ROCE(5y)4.15%
ROICexcg growth 3Y-27.26%
ROICexcg growth 5Y-28.59%
ROICexc growth 3Y-23.81%
ROICexc growth 5Y-28.43%
OM growth 3Y-31.88%
OM growth 5Y-30.13%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-7.12%
GM growth 5Y-8.31%
F-Score5
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 2.65
Debt/FCF 33.07
Debt/EBITDA 6.52
Cap/Depr 40.2%
Cap/Sales 2.92%
Interest Coverage 0.36
Cash Conversion 52.76%
Profit Quality N/A
Current Ratio 2.38
Quick Ratio 1.18
Altman-Z 1.21
F-Score5
WACC8.92%
ROIC/WACC0.16
Cap/Depr(3y)43.24%
Cap/Depr(5y)43.56%
Cap/Sales(3y)2.94%
Cap/Sales(5y)2.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-52.58%
EPS 3Y-38.46%
EPS 5Y-29.46%
EPS Q2Q%-800%
EPS Next Y1.18%
EPS Next 2Y23.36%
EPS Next 3Y24.04%
EPS Next 5YN/A
Revenue 1Y (TTM)-22.19%
Revenue growth 3Y11.22%
Revenue growth 5Y14.14%
Sales Q2Q%-3.08%
Revenue Next Year-0.63%
Revenue Next 2Y0.82%
Revenue Next 3Y0.69%
Revenue Next 5Y1.28%
EBIT growth 1Y116.55%
EBIT growth 3Y-24.24%
EBIT growth 5Y-20.26%
EBIT Next Year4232.08%
EBIT Next 3Y267.29%
EBIT Next 5YN/A
FCF growth 1Y-67.85%
FCF growth 3Y26.86%
FCF growth 5Y-20.85%
OCF growth 1Y-47.93%
OCF growth 3Y17.73%
OCF growth 5Y-9.97%